Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/13830
Title: Synthesis of 2-Furyl[(4-aralkyl)-1-piperazinyl]methanone derivatives as suitable antibacterial agents with mild cytotoxicity
Authors: Abbasi, Muhammad Athar
Nazeer, Muhammad Mubashar
Rehman, Aziz-ur
Siddiqui, Sabahat Zahra
Hussain, Ghulam
Shah, Syed Adnan Ali
Ahmad, Irshad
Shahid, Muhammad
Sarwar, Muhammad Salman
Keywords: Furyl(-1-piperazinyl)methanone
aralkyl halides
antibacterial activity
cytotoxicity studies
Issue Date: Nov-2018
Publisher: Pakistan Journal of Pharmaceutical Sciences University of Karachi
Citation: Abbasi, M. A., Nazeer, M. M., Siddiqui, S. Z., Hussain, G., Shah, S. A. A., Ahmad, I., ... & Sarwar, M. S. (2018). Synthesis of 2-Furyl [(4-aralkyl)-1-piperazinyl] methanone derivatives as suitable antibacterial agents with mild cytotoxicity. Pakistan journal of pharmaceutical sciences, 31(6).
Abstract: The aim of the present research work was synthesis of some 2-furyl[(4-aralkyl)-1-piperazinyl]methanone derivatives and to ascertain their antibacterial potential. The cytotoxicity of these molecules was also checked to find out their utility as possible therapeutic agents. The synthesis was initiated by reacting furyl(-1-piperazinyl)methanone (1) in N,N-dimethylformamide (DMF) and lithium hydride with different aralkyl halides (2a-j) to afford 2-furyl[(4-aralkyl)-1- piperazinyl]methanone derivatives (3a–j). The structural confirmation of all the synthesized compounds was done by IR, EI-MS, 1 H-NMR and 13C-NMR spectral techniques and through elemental analysis. The results of in vitro antibacterial activity of all the synthesized compounds were screened against Gram-negative (S. typhi, E. coli, P. aeruginosa) and Gram-positive (B. subtilis, S. aureus) bacteria and were found to be decent inhibitors. Amongst the synthesized molecules, 3e showed lowest minimum inhibitory concentration MIC = 7.52±0.µg/mL against S. Typhi, credibly due to the presence of 2-bromobenzyl group, relative to the reference standard, ciprofloxacin, having MIC = 7.45±0.58µg/mL.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/13830
ISSN: 1996-7195
Appears in Collections:Issue No. 86

Files in This Item:
File Description SizeFormat 
Paper-23.htm131 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.